Author:
Negi Anjana K.,Kansal Shevali,Bhatnagar Archana,Agnihotri Navneet
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Gonenc A, Ozkan Y, Torun M, Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001;26:141–4.
2. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, et al. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998;58:3761–4.
3. Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer Lett. 2002;184:7–12.
4. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenese-2: A novel target for cancer chemotherapy? J Cancer Res Clin Oncol. 2001;127:411–7.
5. Harris RE, Alshafie GA, Abou-Issa H, Seibert K. Chemoprevention of breast cancer in rats by celecoxib cyclooxygenase 2 inhibitor. Cancer Res. 2000;60:2101–3.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献